Pulmonary nocardiosis in cystic fibrosis Shannon T. Thorn, Mark A. Brown, James J. Yanes, Duane L. Sherrill, Juliana Pugmire, K. Arbor Anderson, Stephen A. Klotz Journal of Cystic Fibrosis Volume 8, Issue 5, Pages 316-320 (September 2009) DOI: 10.1016/j.jcf.2009.07.005 Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions
Fig. 1 Averages of FEV1 values for each subject 180 days before and 180 days after antibiotic start date (start date=0) for each episode. The mean values for each subject are a different color. Two subjects did not receive antibiotics and were not included in this graph. The bold black line represents an aggregate of all patient values. Journal of Cystic Fibrosis 2009 8, 316-320DOI: (10.1016/j.jcf.2009.07.005) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions
Fig. 2 Averages of FVC values for each subject 180 days before and 180 days after antibiotic start date (start date=0). The mean values for each subject are a different color. The bold black line represents an aggregate of all patient values. Journal of Cystic Fibrosis 2009 8, 316-320DOI: (10.1016/j.jcf.2009.07.005) Copyright © 2009 European Cystic Fibrosis Society. Terms and Conditions